← Back to Clinical Trials
Recruiting NCT06630598

NCT06630598 Impacts of the VEGA Family Violence Education Resources for Psychology Trainees

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06630598
Status Recruiting
Phase
Sponsor University of Ottawa
Condition Family Violence
Study Type INTERVENTIONAL
Enrollment 90 participants
Start Date 2024-10-30
Primary Completion 2025-03

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Online Family Violence Education Resource

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 90 participants in total. It began in 2024-10-30 with a primary completion date of 2025-03.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The current research project aims to assess the effectiveness of the ©Violence, Evidence, Guidance, and Action (VEGA) Family Violence Education Resources (VEGA Project, 2019) in improving the knowledge, self-efficacy, and clinical responses of clinical psychology doctoral students to family violence in clinical settings. The VEGA on-line training is a collection of family violence online education resources designed to inform health and social service practitioners about family violence in a Canadian context, including definitions of family violence, mandatory reporting duties, effective responding to survivors, and more. Participants in this trial will be doctoral students recruited from accredited Clinical Psychology programs across Canada. Participants will be assigned to an intervention or wait-list control group, and the outcome measures consist of knowledge and attitudes about family violence, as well as measures of skills relevant to appropriately responding to survivors in clinical settings. Further, participants will be invited to complete a qualitative interview after the intervention to discuss overall impressions of the training and other ways the training changed their perspectives, if at all, on family violence.

Eligibility Criteria

Inclusion Criteria: * Be a student in the Clinical Psychology graduate program of a Canadian university. * Be engaged in clinical work as part of program requirements * Speak and read English * Have internet access Exclusion Criteria: -Currently participating in any other training relating to child maltreatment or intimate partner violence outside of mandatory or elective course material.

Contact & Investigator

Central Contact

Carl Newton, M.A., Applied Psychology

✉ cnewt058@uottawa.ca

📞 1-613-562-5800

Principal Investigator

Elisa Romano, PhD, Clinical Psychology

PRINCIPAL INVESTIGATOR

University of Ottawa

Frequently Asked Questions

Who can join the NCT06630598 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Family Violence. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06630598 currently recruiting?

Yes, NCT06630598 is actively recruiting participants. Contact the research team at cnewt058@uottawa.ca for enrollment information.

Where is the NCT06630598 trial being conducted?

This trial is being conducted at Ottawa, Canada.

Who is sponsoring the NCT06630598 clinical trial?

NCT06630598 is sponsored by University of Ottawa. The principal investigator is Elisa Romano, PhD, Clinical Psychology at University of Ottawa. The trial plans to enroll 90 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology